| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671541 | Clinical Microbiology and Infection | 2017 | 12 Pages |
Abstract
New HCV infections have a rapidly progressive course in this population. Persons with HIV and HCV superinfection should be prioritized for treatment with anti-HCV direct-acting antivirals.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Puoti, P. Lorenzini, A. Cozzi-Lepri, A. Gori, C. Mastroianni, G. Rizzardini, G. Mazzarello, A. Antinori, A. d'Arminio Monforte, E. Girardi,